R01AI172846

Structure and Function of Tetraspanin Complexes - Project Summary

Tetraspanins are an ancient and exceptionally well-conserved family of four-pass transmembrane proteins – numbering 33 unique members in humans – that have essential but poorly understood functions in many different cellular contexts. Among tetraspanin proteins, CD81 and the C8 subfamily stand out as particularly important in human biology. CD81 is a binding partner of CD19 in the B cell co-receptor complex, a key regulator of B cell receptor (BCR) signaling.

Relatively little is known, however, about how the dynamic association of CD81 with CD19 regulates its association with the B cell receptor and ability to induce a signaling response, critical knowledge gaps that impede therapeutic efforts to modulate or target this pathway.

The subset of tetraspanins with eight extracellular cysteine residues (the "C8" tetraspanins) facilitate the maturation and function of the transmembrane metalloprotease ADAM10, which has numerous important roles in physiology and disease. In the immune system, ADAM10 promotes T cell proliferation and cytokine production as the primary sheddase of the low-affinity IgE receptor CD23, and it cleaves LAG-3 in response to stimulation of the T cell receptor. ADAM10 also catalyzes ligand-dependent physiologic Notch cleavage, an essential step in Notch signal transduction, and is the protease responsible for constitutive alpha secretase processing of the Alzheimer's precursor protein APP, resulting in production of a non-toxic product instead of the toxic A-beta (ASS) fragment produced by beta-secretase.

The objective of this work is to provide a deep and comprehensive understanding of the molecular basis for the function of CD81 and the C8 tetraspanins using structural, biochemical, and dynamic approaches, building from our recent progress in visualizing the structure of CD81 in its free and CD19-bound states. To achieve this goal, we plan to elucidate the dynamics of the CD19-CD81 co-receptor complex in response to B cell activation, determine the molecular basis for recognition of ADAM10 by C8 tetraspanins, and uncover how C8-tetraspanin binding to ADAM10 modulates substrate selection and proteolytic activity.

Together, successful completion of these aims will provide a deep understanding of how CD81 modulates signal transduction by the B cell co-receptor, and how the C8 tetraspanins influence ADAM10 metalloprotease function. These findings will inform future therapeutic efforts targeting these important biological processes.

President And Fellows Of Harvard College

TO ASSIST PUBLIC AND PRIVATE NONPROFIT INSTITUTIONS AND INDIVIDUALS TO ESTABLISH, EXPAND AND IMPROVE BIOMEDICAL RESEARCH AND RESEARCH TRAINING IN INFECTIOUS DISEASES AND RELATED AREAS, TO CONDUCT DEVELOPMENTAL RESEARCH, TO PRODUCE AND TEST RESEARCH MATERIALS. TO ASSIST PUBLIC, PRIVATE AND COMMERCIAL INSTITUTIONS TO CONDUCT DEVELOPMENTAL RESEARCH, TO PRODUCE AND TEST RESEARCH MATERIALS, TO PROVIDE RESEARCH SERVICES AS REQUIRED BY THE AGENCY FOR PROGRAMS IN INFECTIOUS DISEASES, AND CONTROLLING DISEASE CAUSED BY INFECTIOUS OR PARASITIC AGENTS, ALLERGIC AND IMMUNOLOGIC DISEASES AND RELATED AREAS. PROJECTS RANGE FROM STUDIES OF MICROBIAL PHYSIOLOGY AND ANTIGENIC STRUCTURE TO COLLABORATIVE TRIALS OF EXPERIMENTAL DRUGS AND VACCINES, MECHANISMS OF RESISTANCE TO ANTIBIOTICS AS WELL AS RESEARCH DEALING WITH EPIDEMIOLOGICAL OBSERVATIONS IN HOSPITALIZED PATIENTS OR COMMUNITY POPULATIONS AND PROGRESS IN ALLERGIC AND IMMUNOLOGIC DISEASES. BECAUSE OF THIS DUAL FOCUS, THE PROGRAM ENCOMPASSES BOTH BASIC RESEARCH AND CLINICAL RESEARCH. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM EXPANDS AND IMPROVES PRIVATE SECTOR PARTICIPATION IN BIOMEDICAL RESEARCH. THE SBIR PROGRAM INTENDS TO INCREASE AND FACILITATE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. THE SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM STIMULATES AND FOSTERS SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH AND DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. RESEARCH CAREER DEVELOPMENT AWARDS SUPPORT THE DEVELOPMENT OF SCIENTISTS DURING THE FORMATIVE STAGES OF THEIR CAREERS. INDIVIDUAL NATIONAL RESEARCH SERVICE AWARDS (NRSAS) ARE MADE DIRECTLY TO APPROVE APPLICANTS FOR RESEARCH TRAINING IN SPECIFIED BIOMEDICAL SHORTAGE AREAS. IN ADDITION, INSTITUTIONAL NATIONAL RESEARCH SERVICE AWARDS ARE MADE TO ENABLE INSTITUTIONS TO SELECT AND MAKE AWARDS TO INDIVIDUALS TO RECEIVE TRAINING UNDER THE AEGIS OF THEIR INSTITUTIONAL PROGRAM.

93.855 - Allergy and Infectious Diseases Research

National Institute of Allergy and Infectious Diseases (NIAID) [HHS - NIH]

Boston, Massachusetts 021156012 United States

Single Zip Code

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) (PA-20-185)

Amendment Since initial award the total obligations have increased 308% from $777,954 to $3,174,483.